| 4,716 | 175 | 362 |
| 下载次数 | 被引频次 | 阅读次数 |
人类辅助生殖技术(ART)临床操作流程多而复杂,如何有效选取并利用关键指标对临床操作进行全面质量管理(TQM)显得尤为关键。因此,中华医学会生殖医学分会制定"辅助生殖技术临床关键指标质控专家共识",为我国各地生殖中心从事生殖医学的临床医务工作者对其进行有效的质量管理提供参考。
Abstract:The procedures for clinical operation of assisted reproductive technology(ART)are numerous and complex.It is important for total quality management in clinical operation by effectively choosing and utilizing the key indicators.Thus,Chinese Society of Reproductive Medicine drew the consensus to provide reference for the effective quality management to the clinical medical workers engaged in reproductive medicine in reproductive centers across China.
[1]Ackoff RL.The“total”in Total Quality Management(TQM)[J].Syst Pract,1992,5:367-369.
[2]Esteves S,Bento F,Agarwal A.Quality management in ART clinics:apractical guide[M].Boston:Springer,2013.
[3]人类辅助生殖技术管理办法(2001年2月20日卫生部令第14号发布)[J].中国卫生法制,2001,9:38-39.
[4]卫生部关于修订人类辅助生殖技术和人类精子库相关技术规范、标准及伦理原则的通知[Z].卫教科发[2003]176号.
[5]Gallot V,Berwanger da Silva AL,Genro V,et al.Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe(FORT)may predict in vitro fertilization-embryo transfer outcome[J].Hum Reprod,2012,27:1066-1072.
[6]Brezina PR,Mensah V,Balen A,et al.Fertility management in the PCOS population:results of a web-based survey at IVFworldwide.com[J].J Assist Reprod Genet,2013,30:1169-1174.
[7]Peng CW,Jie Q,Ha C,et al.Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy:an Asian perspective[J/OL].Reprod Biomed Online,2011,23:81-90.
[8]Devine K,Mumford SL,Wu M,et al.Diminished ovarian reserve in the United States assisted reproductive technology population:diagnostic trends among 181,536cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System[J].Fertil Steril,2015,104:612-619.
[9]Genro VK,Grynberg M,Scheffer JB,et al.Serum antiMüllerian hormone levels are negatively related to Follicular Output RaTe(FORT)in normo-cycling women undergoing controlled ovarian hyperstimulation[J].Hum Reprod,2011,26:671-677.
[10]Garrido N,Bellver J,RemohíJ,et al.Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization(IVF)cycles:a new approach to measuring the likelihood of IVF success[J].Fertil Steril,2011,96:40-46.
[11]Sunkara SK,Rittenberg V,Rainefenning N,et al.Association between the number of eggs and live birth in IVF treatment:an analysis of 400 135treatment cycles[J].Hum Reprod,2011,26:1768-1774.
[12]Nastri CO,Teixeira DM,Moroni RM,et al.Ovarian hyperstimulation syndrome:pathophysiology,staging,prediction and prevention[J].Ultrasound Obstet Gynecol,2015,45:377-393.
[13]Gera PS,Tatpati LL,Allemand MC,et al.Ovarian hyperstimulation syndrome:steps to maximize success and minimize effect for assisted reproductive outcome[J].Fertil Steril,2010,94:173-178.
[14]Hsu MI,Wang CW,Chen CH,et al.Impact of the number of retrieved oocytes on pregnancy outcome in in vitro fertilization[J].Taiwan J Obstet Gynecol,2016,55:821-825.
[15]Drakopoulos P,Blockeel C,Stoop D,et al.Conventional ovarian stimulation and single embryo transfer for IVF/ICSI.How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?[J].Hum Reprod,2016,31:370-376.
[16]Baker VL,Brown MB,Luke B,et al.Gonadotropin dose is negatively correlated with live birth rate:analysis of over 650,000ART cycles[J].Fertil Steril,2015,104:1145-1152.e1-5.
[17]Ji J,Liu Y,Tong XH,et al.The optimum number of oocytes in IVF treatment:an analysis of 2455cycles in China[J].Hum Reprod,2013,28:2728-2734.
[18]Xia P.Intracytoplasmic sperm injection:correlation of oocyte grade based on polar body,perivitelline space and cytoplasmic inclusions with fertilization rate and embryo quality[J].Hum Reprod,1997,12:1750-1755.
[19]Zhang N,Hao CF,Zhuang LL,et al.Prediction of IVF/ICSI outcome based on the follicular output rate(FORT)[J/OL].Reprod Biomed Online,2013,27:147-153.
[20]Troncoso C,Bosch E,Rubio C,et al.The origin of biochemical pregnancies:lessons learned from preimplantation genetic diagnosis[J].Fertil Steril,2003,79:449-450.
[21]Verhagen TE,Dumoulin JC,Evers JL,et al.What is the most accurate estimate of pregnancy rates in IVF dropouts?[J].Hum Reprod,2008,23:1793-1799.
[22]Mclernon DJ,Maheshwari A,Lee AJ,et al.Cumulative live birth rates after one or more complete cycles of IVF:a population-based study of linked cycle data from 178,898women[J].Hum Reprod,2016,31:572-581.
[23]European IVF-Monitoring Consortium(EIM)for the European Society of Human Reproduction and Embryology(ESHRE),Calhaz-Jorge C,de Geyter C,et al.Assisted reproductive technology in Europe,2012:results generated from European registers by ESHRE.[J].Hum Reprod,2016,31:1638-1652.
[24]Koivurova S,Hartikainen AL,Gissler M,et al.Neonatal outcome and congenital malformations in children born after in-vitro fertilization[J].Hum Reprod,2002,17:1391-1398.
[25]Davies MJ,Moore VM,Willson KJ,et al.Reproductive technologies and the risk of birth defects[J].N Engl J Med,2012,366:1803-1813.
[26]Halliday JL,Ukoumunne OC,Baker HW,et al.Increased risk of blastogenesis birth defects,arising in the first 4 weeks of pregnancy,after assisted reproductive technologies[J].Hum Reprod,2010,25:59-65.
[27]Keane KN,Cruzat VF,Wagle SR,et al.Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome[J].Reprod Biol,2017,17:51-59.
[28]Brodin T,Hadziosmanovic N,Berglund L,et al.Comparing four ovarian reserve markers-associations with ovarian response and live births after assisted reproduction[J].Acta Obstet Gynecol Scand,2015,94:1056-1063.
[29]La Marca A,Sunkara SK.Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers:from theory to practice[J].Hum Reprod Update,2014,20:124-140.
[30]Vural B,Cakiroglu Y,Vural F,et al.Hormonal and functional biomarkers in ovarian response[J].Arch Gynecol Obstet,2014,289:1355-1361.
[31]Polyzos NP,Devroey P.Systematic review of randomized trials for the treatment of poor ovarian responders:is there any light at the end of the tunnel?[J].Fertil Steril,2011,96:1058-1061.
[32]Ferraretti AP,La Marca A,Fauser BC,et al.ESHRE consensus on the definition of‘poor response’to ovarian stimulation for in vitro fertilization:the Bologna criteria[J].Hum Reprod,2011,26:1616-1624.
[33]Gardner DK,Weissman A,Howles CM,et al.Textbook of Assisted Reproductive Technologies(Laboratory and Clinical Perspectives),third edition[M].UK:Informa Press,2009:761.
[34]Polyzos NP,Sunkara SK.Sub-optimal responders following controlled ovarian stimulation:an overlooked group?[J].Hum Reprod,2015,30:2005-2008.
[35]Broekmans FJ,Soules MR,Fauser BC.Ovarian aging:mechanisms and clinical consequences[J].Endocr Rev,2009,30:465-493.
[36]National Summary Assisted Reproductive Technology(ART)Report[R].CDC Reproductive Health.http:∥nccd.cdc.gov/DRH_ART/Apps/National Summary Report.aspx.
[37]Gunby J,Bissonnette F,Librach C,et al.Assisted reproductive technologies(ART)in Canada:2006results from the Canadian ART Register[J].Fertil Steril,2010,93:2189-2201.
[38]Ballester M,Oppenheimer A,Mathieud E,et al.Deep infiltrating endometriosis is a determinant factor of cumulative pregnancy rate after intracytoplasmic sperm injection/in vitro fertilization cycles in patients with endometriomas[J].Fertil Steril,2012,97:367-372.
[39]Zegershochschild F,Adamson GD,De Mouzon J,et al.The International Committee for Monitoring Assisted Reproductive Technology(ICMART)and the World Health Organization(WHO)Revised Glossary on ART Terminology,2009[J].Fertil Steril,2009,92:1520-1524.
[40]Niinimki M,Veleva Z,Martikainen H.Embryo quality is the main factor affecting cumulative live birth rate after elective single embryo transfer in fresh stimulation cycles[J].Eur J Obstet Gynecol Reprod Biol,2015,194:131-135.
[41]Practice Committee of the American Society for Reproductive Medicine.Testing and interpreting measures of ovarian reserve:a committee opinion.[J].Fertil Steril,2015,103:e9-e17.
[42]Irani M,Reichman D,Robles A,et al.Morphologic grading of euploid blastocysts influences implantation and ongoing pregnancy rates[J].Fertil Steril,2017,107:664-670.
[43]Simon A,Laufer N.Assessment and treatment of repeated implantation failure(RIF)[J].J Assist Reprod Genet,2012,29:1227-1239.
[44]Clancy KB.Reproductive ecology and the endometrium:physiology,variation,and new directions[J].Am J Phys Anthropol,2009,140:137-154.
[45]Wu T,Yin B,Zhu Y,et al.Molecular cytogenetic analysis of early spontaneous abortions conceived from varying assisted reproductive technology procedures[J].Mol Cytogenet,2016,9:79.doi:10.1186/s13039-016-0284-2.eCollection 2016.
[46]Lin S,Yang R,Chi H,et al.Increased incidence of ectopic pregnancy after in vitro fertilization in women with decreased ovarian reserve[J].Oncotarget,2017,8:14570-14575.
[47]Chen YH,Xu XH,Wang Q,et al.Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol:a retrospective cohort study[J].J Assist Reprod Genet,2015,32:1459-1467.
基本信息:
中图分类号:R714.8
引用信息:
[1]胡琳莉,黄国宁,孙海翔,等.辅助生殖技术临床关键指标质控专家共识[J].生殖医学杂志,2018,27(09):828-835.